MINNEAPOLIS, Nov. 5 ATS Medical, Inc. (Nasdaq: ATSI), manufacturer and marketer of state-of-the-art cardiac surgery products, announced today that it will participate at the Rodman & Renshaw Annual Global Investment Conference at the New York Palace Hotel. Michael Kramer, Chief Financial Officer of ATS Medical, will present at 10:45 a.m. Eastern Time on Monday, November 10th, 2008.
Attendance at the conference is by invitation only. A live audio-only webcast of the presentation will be broadcast via the Internet. Those interested in listening to the webcast may access it at ATS Medical's website at www.atsmedical.com. An archived replay of the presentation will also be available approximately one hour following the live presentation at www.atsmedical.com.
About ATS Medical
ATS Medical, Inc. provides innovative products and services focused on cardiac surgery. The Company, global in scope, is headquartered in Minneapolis, Minnesota. More than 160,000 ATS Open Pivot(R) Heart Valves, which utilize a unique pivot design resulting in exceptional performance and low risk profile, have been implanted in patients worldwide. The ATS 3f(R) brand encompasses multiple tissue heart valve product offerings at varying steps from market introductions to clinical trials to development projects that incorporate less invasive valve replacement technology. ATS Medical's focus on serving the cardiac surgery community is further strengthened by offerings that include ATS Simulus(R) annuloplasty products for heart valve repair and ATS CryoMaze(TM) surgical ablation products. The ATS Medical web site is http://www.atsmedical.com.
SOURCE ATS Medical, Inc.